Ben has more than 20 years of experience in life sciences. Prior to Tenpoint, he co-founded and served as Chief Executive Officer of Visus Therapeutics, Inc. beginning in October 2019. He previously served as Executive Vice President of Corporate Development at Planet Innovation, where he led licensing and M&A transactions on behalf of the Planet Group. Additionally, he served as Co-founder and CEO at Nohla Therapeutics, Inc., a leader in the development of off-the-shelf cell therapies utilizing proprietary expanded cord blood formulations. Prior to this, he spun out technologies from Harvard University into a diagnostics venture that was later sold in 2015.
He received a Master’s in Applied Finance from Macquarie University as well as a Bachelor of Engineering and a Bachelor of Commerce in Economics and Finance, both from the University of Melbourne.
